GMO: Fourth Quarter 2011

0
GMO: Fourth Quarter 2011
Click to Enlarge

Performance:

The International Active Strategy narrowly underperformed the MSCI EAFE index in the fourth quarter; the strategy gained 3.2% and the benchmark rose 3.3%. Negative country selection was somewhat offset by positive stock selection. The strategy beat its benchmark by 0.5 percentage points for the year 2011, returning -11.7%.

Click to Enlarge

GMO

Abacab Fund Sees Mispricing In Options As Black-Scholes Has Become “Inadequate”

Abacab Asset Management's flagship investment fund, the Abacab Fund, had a "very strong" 2020, returning 25.9% net, that's according to a copy of the firm's year-end letter to investors, which ValueWalk has been able to review. Commenting on the investment environment last year, the fund manager noted that, due to the accelerated adoption of many Read More


ValueWalk Premium Subscription Includes:

  • 3 Write-ups per month (EXCLUSIVE content that you won’t find anywhere else)
  • Personal Track Record from Jacob’s Brokerage
  • Any question you have answered within 48 hours
GMO: Fourth Quarter 2011

No posts to display